Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.

Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.

Paccar, Uber and Volvo Group are taking part in a $1bn PIPE supporting the autonomous driving technology developer’s reverse merger with Reinvent Technology Partners.

The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.

Samsung, NTT Docomo and Huya helped the livestreaming technology provider close a round that took its overall funding to $166m.

The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.

Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.

WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.

Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.

Softbank enabled the cybersecurity software provider Cybereason to secure crossover financing at a valuation likely to have exceeded $3bn. This year seems set to be a record one for the broader corporate-backed cybersecurity space, with valuations spiking up.